Pirtobrutinib Plus Methotrexate-Based Chemoimmunotherapy for Systemic DLBCL With CNS Involvement

by | Sep 10, 2026 | Clinical Trials | 0 comments

​ Conditions: Pirtobrutinib; Immunochemotherapy; DLBCL – Diffuse Large B Cell Lymphoma; CNS Involvement of Systemic Lymphoma

Interventions: Drug: pirtobrutinib+MTX+immunolchemotherapy

Sponsors: Pengpeng Xu

Not yet recruiting Conditions: Pirtobrutinib; Immunochemotherapy; DLBCL – Diffuse Large B Cell Lymphoma; CNS Involvement of Systemic Lymphoma
Interventions: Drug: pirtobrutinib+MTX+immunolchemotherapy
Sponsors: Pengpeng Xu
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *